Pathways of metastasis suppression in bladder cancer

Cancer and Metastasis Reviews

Volumn 28, Issue 3-4, 2009, Pages 327-333

  Said, Neveen ^a   Theodorescu, Dan ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bladder neoplasms; Metastasis; RhoGDI2; Src

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RHO FAMILY GDP DISSOCIATION INHIBITOR 2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER GROWTH; CANCER RECURRENCE; CYSTECTOMY; DISTANT METASTASIS; ENZYME ACTIVATION; ENZYME STRUCTURE; HUMAN; METASTASIS INHIBITION; ONCOGENE SRC; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; REVIEW;

AMINO ACID SEQUENCE; CARCINOMA, TRANSITIONAL CELL; CONSERVED SEQUENCE; CYSTECTOMY; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SRC-FAMILY KINASES; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 76649127722     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-009-9197-4     Document Type: Review

References (66)

1. A Jemal, et al. 2009 Cancer statistics, 2009 CA: A Cancer Journal for Clinicians 59 4 225 249 10.3322/caac.20006
2. CP Dinney, et al. 2004 Focus on bladder cancer Cancer Cell 6 2 111 116 10.1016/j.ccr.2004.08.002 1:CAS:528:DC%2BD2cXns1arsr4%3D 15324694 (Pubitemid 39485683)
3. JP Stein, et al. 2001 Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients Journal of Clinical Oncology 19 3 666 675 1:STN:280:DC%2BD3M7kvV2msQ%3D%3D 11157016
4. Theodorescu, D. (2006). Molecular biology of invasive and metastatic urothelial cancer. In S. Lerner, M. Schoenberg, & C. Sternberg (Eds.) Textbook of Bladder Cancer. Taylor and Francis. pp. 147-156.
5. JJ Gildea, et al. 2002 RhoGDI2 is an invasion and metastasis suppressor gene in human cancer Cancer Research 62 22 6418 6423 1:CAS:528: DC%2BD38XovFOlurg%3D 12438227
6. MJ Seraj, et al. 2000 The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines Clinical & Experimental Metastasis 18 6 519 525 10.1023/A: 1011819621859 1:CAS:528:DC%2BD3MXnslSltrg%3D (Pubitemid 32844253)
7. D Theodorescu, et al. 2004 Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer Clinical Cancer Research 10 11 3800 3806 10.1158/1078-0432.CCR-03-0653 1:CAS:528:DC%2BD2cXksVKnt78%3D 15173088 (Pubitemid 38697615)
8. B Titus, et al. 2005 Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2 Cancer Research 65 16 7320 7327 10.1158/0008-5472.CAN- 05-1403 1:CAS:528:DC%2BD2MXns1Wru7w%3D 16103083 (Pubitemid 41161264)
9. Y Wu, et al. 2009 Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function Proceedings of the National Academy of Sciences of the United States of America 106 14 5807 5812 10.1073/pnas.0810094106 1:CAS:528:DC%2BD1MXkvFahsbs%3D 19321744
10. D Stehelin 1976 The transforming gene of avian tumor viruses Pathology and Biology (Paris) 24 8 513 515 1:STN:280:DyaE2s%2FjsFGlsQ%3D%3D
11. D Stehelin, et al. 1976 Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses Journal of Molecular Biology 101 3 349 365 10.1016/0022-2836(76)90152-2 1:CAS:528:DyaE28XhtFygtLc%3D 176368
12. D Stehelin, et al. 1976 DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA Nature 260 5547 170 173 10.1038/260170a0 1:CAS:528:DyaE28XktVWgurs%3D 176594
13. P Rous 1983 Landmark article (JAMA 1911;56:198) Transmission of a malignant new growth by means of a cell-free filtrate. By Peyton Rous. The Journal of the American Medical Association 250 11 1445 1449 1:STN:280:DyaL3s3psVyrtw%3D%3D
14. R Roskoski Jr 2004 Src protein-tyrosine kinase structure and regulation Biochemical and Biophysical Research Communications 324 4 1155 1164 10.1016/j.bbrc.2004.09.171 1:CAS:528:DC%2BD2cXovVKmu7s%3D 15504335 (Pubitemid 40292143)
15. T Takeya H Hanafusa 1983 Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus Cell 32 3 881 890 10.1016/0092-8674(83)90073-9 1:CAS:528: DyaL3sXitFSkt7c%3D 6299580
16. T Takeya, et al. 1981 Comparison between the viral transforming gene (src) of recovered avian sarcoma virus and its cellular homolog Molecular and Cellular Biology 1 11 1024 1037 1:CAS:528:DyaL3MXmtFOmu7s%3D 6287213
17. H Iba, et al. 1984 Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts Proceedings of the National Academy of Sciences of the United States of America 81 14 4424 4428 10.1073/pnas.81.14.4424 1:CAS:528:DyaL2cXlt1Cjs7s%3D 6087323
18. T Takeya H Hanafusa 1982 DNA sequence of the viral and cellular src gene of chickens. II. Comparison of the src genes of two strains of avian sarcoma virus and of the cellular homolog Journal of Virology 44 1 12 18 1:CAS:528:DyaL38XlsFOgsbk%3D 6292480
19. I Moarefi, et al. 1997 Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement Nature 385 6617 650 653 10.1038/385650a0 1:CAS:528:DyaK2sXht1yksb4%3D 9024665 (Pubitemid 27087580)
20. F Sicheri J Kuriyan 1997 Structures of Src-family tyrosine kinases Current Opinion in Structural Biology 7 6 777 785 10.1016/S0959-440X(97)80146-7 1:CAS:528:DyaK1cXjtl2msg%3D%3D 9434895 (Pubitemid 28025103)
21. F Sicheri I Moarefi J Kuriyan 1997 Crystal structure of the Src family tyrosine kinase Hck Nature 385 6617 602 609 10.1038/385602a0 1:CAS:528:DyaK2sXht1ymtLs%3D 9024658 (Pubitemid 27087567)
22. W Xu, et al. 1999 Crystal structures of c-Src reveal features of its autoinhibitory mechanism Molecular Cell 3 5 629 638 10.1016/S1097-2765(00)80356- 1 1:CAS:528:DyaK1MXjslCqu7o%3D 10360179 (Pubitemid 29268446)
23. G Manning, et al. 2002 The protein kinase complement of the human genome Science 298 5600 1912 1934 10.1126/science.1075762 1:CAS:528: DC%2BD38Xpt1Wisb0%3D 12471243 (Pubitemid 35425239)
24. MT Brown JA Cooper 1996 Regulation, substrates and functions of src Biochimica et Biophysica Acta 1287 2-3 121 149 8672527
25. RB Irby TJ Yeatman 2000 Role of Src expression and activation in human cancer Oncogene 19 49 5636 5642 10.1038/sj.onc.1203912 1:CAS:528: DC%2BD3cXosl2nurs%3D 11114744
26. AD Levinson, et al. 1980 The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine Journal of Biological Chemistry 255 24 11973 11980 1:CAS:528:DyaL3cXmtlelsLc%3D 6254988
27. SM Thomas JS Brugge 1997 Cellular functions regulated by Src family kinases Annual Review of Cell and Developmental Biology 13 513 609 10.1146/annurev.cellbio.13.1.513 1:CAS:528:DyaK1cXisFSrsQ%3D%3D 9442882 (Pubitemid 28034534)
28. TJ Yeatman 2004 A renaissance for SRC Nature Reviews. Cancer 4 6 470 480 10.1038/nrc1366 1:CAS:528:DC%2BD2cXksVaisbo%3D 15170449
29. L Alland, et al. 1994 Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization Journal of Biological Chemistry 269 24 16701 16705 1:CAS:528:DyaK2cXksFaltbc%3D 8206991
30. JM Summy GE Gallick 2003 Src family kinases in tumor progression and metastasis Cancer Metastasis Reviews 22 4 337 358 10.1023/A:1023772912750 1:CAS:528:DC%2BD3sXjslyiu74%3D 12884910 (Pubitemid 36791891)
31. JM Summy, et al. 2005 c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK Pancreas 31 3 263 274 10.1097/01.mpa.0000178280. 50534.0c 1:CAS:528:DC%2BD2MXhtFeksbzF 16163059 (Pubitemid 41400485)
32. R Irby, et al. 1997 Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential Cell Growth & Differentiation 8 12 1287 1295 1:CAS:528: DyaK2sXotVWlt7k%3D
33. RB Irby, et al. 1999 Activating SRC mutation in a subset of advanced human colon cancers Nature Genetics 21 2 187 190 10.1038/5971 1:CAS:528:DyaK1MXpsVCksA%3D%3D 9988270 (Pubitemid 29070364)
34. FM Johnson GE Gallick 2007 SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy Anticancer Agents in Medical Chemistry 7 6 651 659 10.2174/187152007784111278 1:CAS:528:DC%2BD2sXhtlWiur%2FL (Pubitemid 350237770)
35. W Mao, et al. 1997 Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential Oncogene 15 25 3083 3090 10.1038/sj.onc.1201496 1:CAS:528:DyaK1cXmtFKqtA%3D%3D 9444956 (Pubitemid 28043487)
36. GJ Chiang, et al. 2005 The src-family kinase inhibitor PP2 suppresses the in vitro invasive phenotype of bladder carcinoma cells via modulation of Akt Journal of the British Association of Urological Surgeons 96 3 416 422 1:CAS:528:DC%2BD2MXpvFehtbs%3D
37. S Kopetz, et al. 2009 Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress Cancer Research 69 9 3842 3849 10.1158/0008-5472.CAN-08-2246 1:CAS:528:DC%2BD1MXltFOksL8%3D 19383922
38. SI Park, et al. 2008 Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model Cancer Research 68 9 3323 3333 10.1158/0008-5472.CAN-07-2997 1:CAS:528:DC%2BD1cXltlSlsL4%3D 18451159
39. B Sen, et al. 2009 Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding Cancer Research 69 5 1958 1965 10.1158/0008-5472.CAN-08-2944 1:CAS:528:DC%2BD1MXisFSrtb8%3D 19223541
40. N Rosen, et al. 1986 Analysis of pp 60c-src protein kinase activity in human tumor cell lines and tissues Journal of Biological Chemistry 261 29 13754 13759 1:CAS:528:DyaL28Xmt1eksbw%3D 3093483
41. P Fanning, et al. 1992 Elevated expression of pp 60c-src in low grade human bladder carcinoma Cancer Research 52 6 1457 1462 1:STN:280: DyaK387nsVWlsA%3D%3D 1371716
42. B Boyer Y Bourgeois MF Poupon 2002 Src kinase contributes to the metastatic spread of carcinoma cells Oncogene 21 15 2347 2356 10.1038/sj.onc.1205298 1:CAS:528:DC%2BD38XivFykurg%3D 11948418
43. JM Rodier, et al. 1995 pp 60c-src is a positive regulator of growth factor-induced cell scattering in a rat bladder carcinoma cell line Journal of Cell Biology 131 3 761 773 10.1083/jcb.131.3.761 1:STN:280: DyaK28%2Fkt1eiuw%3D%3D 7593195
44. JP Thiery D Chopin 1999 Epithelial cell plasticity in development and tumor progression Cancer Metastasis Reviews 18 1 31 42 10.1023/A:1006256219004 1:CAS:528:DyaK1MXns1Cqu7Y%3D 10505544 (Pubitemid 29411090)
45. PP Simeonova, et al. 2002 c-Src-dependent activation of the epidermal growth factor receptor and mitogen-activated protein kinase pathway by arsenic. Role in carcinogenesis Journal of Biological Chemistry 277 4 2945 2950 10.1074/jbc.M109136200 1:CAS:528:DC%2BD38XhtVSgtLo%3D 11723127 (Pubitemid 34953329)
46. KE Eblin, et al. 2007 Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis Toxicological Sciences 95 2 321 330 10.1093/toxsci/kfl160 1:CAS:528:DC%2BD2sXotFCgtw%3D%3D 17093206 (Pubitemid 46152604)
47. N Yamamoto, et al. 2006 Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells Journal of Cell Science 119 Pt 22 4623 4633 10.1242/jcs.03236 1:CAS:528:DC%2BD2sXktF2k 17062641 (Pubitemid 44964259)
48. C DerMardirossian GM Bokoch 2005 GDIs: central regulatory molecules in Rho GTPase activation Trends in Cell Biology 15 7 356 363 10.1016/j.tcb.2005.05. 001 1:CAS:528:DC%2BD2MXlvFygt70%3D 15921909 (Pubitemid 40943524)
49. AP Golovanov, et al. 2001 Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI Journal of Molecular Biology 305 1 121 135 10.1006/jmbi.2000.4262 1:CAS:528: DC%2BD3cXoslSmsrw%3D 11114252 (Pubitemid 32039750)
50. B Olofsson 1999 Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling Cell Signal 11 8 545 554 10.1016/S0898-6568(98)00063-1 1:CAS:528:DyaK1MXkt1emsrc%3D 10433515 (Pubitemid 29255886)
51. T Ota, et al. 2006 RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells Clinical & Experimental Metastasis 23 7-8 323 334
52. RJ Krieser A Eastman 1999 Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis Cell Death and Differentiation 6 5 412 419 10.1038/sj.cdd.4400515 1:CAS:528:DyaK1MXjvFCmsLs%3D 10381642
53. KB Kwon, et al. 2002 D4-GDI is cleaved by caspase-3 during daunorubicin-induced apoptosis in HL-60 cells Experimental and Molecular Medicine 34 1 32 37 1:CAS:528:DC%2BD38Xjt1ekurg%3D 11989976
54. X Zhou, et al. 2004 Nuclear translocation of cleaved LyGDI dissociated from Rho and Rac during Trp53-dependent ionizing radiation-induced apoptosis of thymus cells in vitro Radiation Research 162 3 287 295 10.1667/RR3220 1:CAS:528:DC%2BD2cXns1yisb0%3D 15332996 (Pubitemid 39295429)
55. T Ota, et al. 2004 LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane Molecular Carcinogenesis 39 4 206 220 10.1002/mc.20006 1:CAS:528:DC%2BD2cXjt1egur8%3D 15057873 (Pubitemid 38452241)
56. L Ma, et al. 2007 Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma British Journal of Haematology 139 2 217 223 10.1111/j.1365-2141.2007.06782.x 1:CAS:528:DC%2BD2sXht1yht7fF 17897297 (Pubitemid 47493088)
57. J Tapper, et al. 2001 Changes in gene expression during progression of ovarian carcinoma Cancer Genetics and Cytogenetics 128 1 1 6 10.1016/S0165-4608(01)00386-7 1:CAS:528:DC%2BD3MXltVaku7s%3D 11454421 (Pubitemid 32655473)
58. LD Hu, et al. 2007 Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis Oncology Reports 17 6 1383 1389 17487395
59. B Zhang 2006 Rho GDP dissociation inhibitors as potential targets for anticancer treatment Drug Resistance Updates 9 3 134 141 10.1016/j.drup.2006.06. 001 1:CAS:528:DC%2BD28XoslOgurw%3D 16807067 (Pubitemid 44279520)
60. B Zhang, et al. 2005 Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis Cancer Research 65 14 6054 6062 10.1158/0008-5472.CAN-05-0175 1:CAS:528:DC%2BD2MXmt1ehtLg%3D 16024605 (Pubitemid 40994389)
61. Y Zhang, et al. 2009 Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling Journal of Biological Chemistry 284 19 12956 12965 10.1074/jbc.M807845200 1:CAS:528:DC%2BD1MXltlems7g%3D 19269969
62. Y Wang, et al. 2005 Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 365 9460 671 679 1:CAS:528:DC%2BD2MXhsVOitLk%3D 15721472
63. F Essmann, et al. 2000 GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis Biochemical Journal 346 Pt 3 777 783 10.1042/0264-6021:3460777 1:CAS:528:DC%2BD3cXit1Krs7k%3D 10698706 (Pubitemid 30171040)
64. C DerMardirossian, et al. 2006 Phosphorylation of RhoGDI by Src regulates Rho GTPase binding and cytosol-membrane cycling Molecular Biology of the Cell 17 11 4760 4768 10.1091/mbc.E06-06-0533 1:CAS:528:DC%2BD28XhtFygtr%2FE 16943322 (Pubitemid 44665745)
65. K Moissoglu, et al. 2009 Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases Cancer Research 69 7 2838 2844 10.1158/0008-5472.CAN-08-1397 1:CAS:528:DC%2BD1MXjvVWis78%3D 19276387
66. K Uhlenbrock, et al. 2004 The RacGEF Tiam1 inhibits migration and invasion of metastatic melanoma via a novel adhesive mechanism Journal of Cell Science 117 Pt 20 4863 4871 10.1242/jcs.01367 1:CAS:528:DC%2BD2cXptVygu7w%3D 15340013 (Pubitemid 39433450)